Synergistic effect of combined HMG-CoA reductase inhibitor and angiotensin-II receptor blocker therapy in patients with chronic heart failure: the HF-COSTAR trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation Journal

• Publication date

  2011-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.CJ-10-0804PMID 21242642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of endostatin/collagen XVIII deteriorates left ventricular remodeling and heart failure in rat myocardial infarction model.

  2010cited by this paper
• The future of pharmacological therapy for heart failure.

  2009cited by this paper
• Effects of pretreatment with statins on infarct size in patients with acute myocardial infarction who receive fibrinolytic therapy.

  2009cited by this paper
• Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors.

  2009cited by this paper
• Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• ECM remodeling in hypertensive heart disease.

  2007cited by this paper
• Diastolic Heart Failure: Evidence of Increased Myocardial Collagen Turnover Linked to Diastolic Dysfunction

  2007cited by this paper
• Characteristics and outcomes of patients with heart failure in general practices and hospitals.

  2007cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2007cited by this paper
• Statin Therapy and Risks for Death and Hospitalization in Chronic Heart Failure

  2007cited by this paper
• Statin therapy and risks for death and hospitalization in chronic heart failure.

  2006cited by this paper
• Extracellular matrix remodeling in hypertensive heart disease.

  2006cited by this paper
• HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.

  2006cited by this paper
• Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.

  2006cited by this paper
• Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.

  2006cited by this paper
• Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure.

  2005cited by this paper
• Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.

  2005cited by this paper
• Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.

  2005cited by this paper
• Cardiac Angiotensin II Participates in Coronary Microvessel Inflammation of Unstable Angina and Strengthens the Immunomediated Component

  2004cited by this paper
• Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes

  2004cited by this paper
• Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.

  2003cited by this paper
• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme.

  2003cited by this paper
• Initiation and Transduction of Stretch-induced RhoA and Rac1 Activation through Caveolae

  2003cited by this paper
• Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.

  2003cited by this paper
• Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy

  2003cited by this paper
• Effect of Losartan on Circulating TNFα Levels and Left Ventricular Systolic Performance in Patients with Heart Failure

  2001cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Effect of losartan on circulating TNFalpha levels and left ventricular systolic performance in patients with heart failure.

  2000cited by this paper
• Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes.

  2000cited by this paper
• Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes.

  1999cited by this paper
• Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients.

  1999cited by this paper
• Rho Family Small G Proteins Play Critical Roles in Mechanical Stress–Induced Hypertrophic Responses in Cardiac Myocytes

  1999cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

  1997cited by this paper
• Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

  1997cited by this paper
• The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease.

  1997cited by this paper
• Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

  1994cited by this paper
• Changing epidemiological features of cardiac failure.

  1994cited by this paper
• Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.

  1993cited by this paper
• Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.

  1992cited by this paper
• Brain natriuretic peptide as a cardiac hormone in essential hypertension.

  1992cited by this paper
• The FASEB Journal express article 10.1096/fj.04-2852fje. Published online February 23, 2005. ©2005 FASEB

  year unknowncited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Artificial intelligence-enabled electrocardiography from scientific research to clinical application

  2025cites this paper
• Comparative efficacy of fixed-dose statin and antihypertensive agent combinations: A network meta-analysis of randomized controlled trials.

  2021cites this paper
• Association of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 With Angiotensin II Type 1 Receptor Impacts Mitochondrial Quality Control, Offering Promise for the Treatment of Vascular Senescence

  2021influential citation
• Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure.

  2018cites this paper
• Synergistic effects of HMG‐CoA reductase inhibitor and angiotensin II receptor blocker on load‐induced heart failure

  2018cites this paper
• Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

  2017cites this paper
• Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects

  2015cites this paper
• Statins in heart failure--With preserved and reduced ejection fraction. An update.

  2014cites this paper
• Low-Density Lipoprotein-Cholesterol-Induced Endothelial Dysfunction and Oxidative Stress: The Role of Statins

  2014cites this paper
• Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular disease.

  2014cites this paper
• Effects of pitavastatin on cardiac structure and function and on prevention of atrial fibrillation in elderly hypertensive patients: a prospective study of 2-years' follow-up.

  2012cites this paper
• Effects of pitavastatin on pressure overload-induced heart failure in mice.

  2012cites this paper
• Costarring statins with ARBs: going to be a smash hit?

  2011cites this paper